Eprenetapopt Archives - Medical Conferences

Benefits of eprenetapopt plus azacitidine for TP53-mutant MDS and oligoblastic AML

Presented By

Dr David Sallman, H. Lee Moffitt Cancer Center, FL, USA

Trial

Phase 2

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 11:44

Presented By

Dr Rachel Giles, Medicom

Conference

ASH 2021

4 January 2022 08:00

site created by:

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com